StockpollyBeta
Get App
Delisting riskPopularity #3,921
COSM · NASDAQ · Medical - Pharmaceuticals

Cosmos Health (COSM)

Distributes health products through Greek pharmacies while manufacturing and marketing proprietary healthcare brands.

$0.3958
vs last close+0.04 (+11.74%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue131615131214141517201819
Cost of revenue121513121113121415181717
Gross profit111111213212
415333103441344
Research & development000000000000
41533393321324
Selling & marketing000000000000
General & administrative41433393321324
Other expenses000001002020
Operating income−3−14−2−3−2−9−1−3−2−11−2−3
00000−100−41−1−3
Interest income000000000000
Interest expense000000011111
Other non-operating income000000003−202
Income before tax−3−14−2−3−2−10−1−3−5−10−3−6
Income tax expense000000000000
Net income from continuing operations−3−14−2−3−2−10−1−3−5−10−3−6
Net income−3−14−2−3−2−10−1−3−5−10−3−6
EPS, basic−$0.27−$0.87−$0.11−$0.15−$0.45−$0.50−$0.03−$0.10−$0.17−$0.33−$0.06−$0.10
EPS, diluted−$0.27−$0.87−$0.11−$0.15−$0.45−$0.50−$0.03−$0.10−$0.17−$0.33−$0.06−$0.10
Weighted average shares, basic13917181819262931304760
Weighted average shares, diluted131217181819262931304760
EBITDA−3−13−1−2−2−80−2−4−9−2−5
Depreciation & amortization000000000000
EBIT−3−13−2−2−2−9−1−2−5−9−2−5